vs
Astrana Health, Inc.（ASTH）与CoreCivic, Inc.（CXW）财务数据对比。点击上方公司名可切换其他公司
Astrana Health, Inc.的季度营收约是CoreCivic, Inc.的1.6倍（$950.5M vs $604.0M），CoreCivic, Inc.净利率更高（4.4% vs 0.7%，领先3.7%），Astrana Health, Inc.同比增速更快（42.9% vs 26.0%），Astrana Health, Inc.自由现金流更多（$-6.0M vs $-45.1M），过去两年Astrana Health, Inc.的营收复合增速更高（53.3% vs 9.8%）
Astrana Health是一家总部位于美国的价值导向型医疗服务提供商，主要服务全美符合联邦医保资格的老年群体，提供上门初级护理、慢性病管理及护理协调服务，致力于提升患者健康水平、降低不必要的医疗支出。
CoreCivic, Inc.是美国私营监狱运营企业，为美国规模最大的营利性监狱、看守所及拘留设施承包商之一。该公司在美国运营70余座州级及联邦惩教、拘留场所，曾因相关场所被指存在民权侵犯、强迫劳动问题，成为撤资运动针对对象，还遭到FBI调查及多起诉讼。
ASTH vs CXW — 直观对比
营收规模更大
ASTH
是对方的1.6倍
$604.0M
营收增速更快
ASTH
高出16.9%
26.0%
净利率更高
CXW
高出3.7%
0.7%
自由现金流更多
ASTH
多$39.2M
$-45.1M
两年增速更快
ASTH
近两年复合增速
9.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $950.5M | $604.0M |
| 净利润 | $6.6M | $26.5M |
| 毛利率 | — | — |
| 营业利润率 | 1.9% | 6.0% |
| 净利率 | 0.7% | 4.4% |
| 营收同比 | 42.9% | 26.0% |
| 净利润同比 | 184.4% | 37.7% |
| 每股收益（稀释后） | $0.12 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASTHCXW
| Q4 25 | $950.5M | $604.0M | ||
| Q3 25 | $956.0M | $580.4M | ||
| Q2 25 | $654.8M | $538.2M | ||
| Q1 25 | $620.4M | $488.6M | ||
| Q4 24 | $665.2M | $479.3M | ||
| Q3 24 | $478.7M | $491.6M | ||
| Q2 24 | $486.3M | $490.1M | ||
| Q1 24 | $404.4M | $500.7M |
净利润ASTHCXW
| Q4 25 | $6.6M | $26.5M | ||
| Q3 25 | $373.0K | $26.3M | ||
| Q2 25 | $9.4M | $38.5M | ||
| Q1 25 | $6.7M | $25.1M | ||
| Q4 24 | $-7.8M | $19.3M | ||
| Q3 24 | $16.1M | $21.1M | ||
| Q2 24 | $19.2M | $19.0M | ||
| Q1 24 | $14.8M | $9.5M |
营业利润率ASTHCXW
| Q4 25 | 1.9% | 6.0% | ||
| Q3 25 | 2.0% | 6.3% | ||
| Q2 25 | 3.1% | 9.7% | ||
| Q1 25 | 3.3% | 6.6% | ||
| Q4 24 | 0.1% | 5.2% | ||
| Q3 24 | 5.9% | 6.1% | ||
| Q2 24 | 6.2% | 5.6% | ||
| Q1 24 | 7.5% | 1.8% |
净利率ASTHCXW
| Q4 25 | 0.7% | 4.4% | ||
| Q3 25 | 0.0% | 4.5% | ||
| Q2 25 | 1.4% | 7.2% | ||
| Q1 25 | 1.1% | 5.1% | ||
| Q4 24 | -1.2% | 4.0% | ||
| Q3 24 | 3.4% | 4.3% | ||
| Q2 24 | 3.9% | 3.9% | ||
| Q1 24 | 3.7% | 1.9% |
每股收益（稀释后）ASTHCXW
| Q4 25 | $0.12 | $0.26 | ||
| Q3 25 | $0.01 | $0.24 | ||
| Q2 25 | $0.19 | $0.35 | ||
| Q1 25 | $0.14 | $0.23 | ||
| Q4 24 | $-0.14 | $0.18 | ||
| Q3 24 | $0.33 | $0.19 | ||
| Q2 24 | $0.40 | $0.17 | ||
| Q1 24 | $0.31 | $0.08 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $429.5M | $97.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $779.3M | $1.4B |
| 总资产 | $2.2B | $3.3B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASTHCXW
| Q4 25 | $429.5M | $97.9M | ||
| Q3 25 | $463.4M | $56.6M | ||
| Q2 25 | $342.1M | $130.5M | ||
| Q1 25 | $260.9M | $74.5M | ||
| Q4 24 | $290.8M | $107.5M | ||
| Q3 24 | $350.3M | $107.8M | ||
| Q2 24 | $327.7M | $60.2M | ||
| Q1 24 | $337.3M | $111.4M |
股东权益ASTHCXW
| Q4 25 | $779.3M | $1.4B | ||
| Q3 25 | $775.5M | $1.5B | ||
| Q2 25 | $765.5M | $1.5B | ||
| Q1 25 | $745.4M | $1.5B | ||
| Q4 24 | $712.7M | $1.5B | ||
| Q3 24 | $704.6M | $1.5B | ||
| Q2 24 | $678.9M | $1.4B | ||
| Q1 24 | $653.5M | $1.4B |
总资产ASTHCXW
| Q4 25 | $2.2B | $3.3B | ||
| Q3 25 | $2.2B | $3.1B | ||
| Q2 25 | $1.4B | $3.1B | ||
| Q1 25 | $1.3B | $3.0B | ||
| Q4 24 | $1.4B | $2.9B | ||
| Q3 24 | $1.3B | $2.9B | ||
| Q2 24 | $1.3B | $2.9B | ||
| Q1 24 | $1.2B | $3.0B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.9M | $-376.0K |
| 自由现金流经营现金流 - 资本支出 | $-6.0M | $-45.1M |
| 自由现金流率自由现金流/营收 | -0.6% | -7.5% |
| 资本支出强度资本支出/营收 | 0.3% | 7.4% |
| 现金转化率经营现金流/净利润 | -0.44× | -0.01× |
| 过去12个月自由现金流最近4个季度 | $104.5M | $52.8M |
8季度趋势，按日历期对齐
经营现金流ASTHCXW
| Q4 25 | $-2.9M | $-376.0K | ||
| Q3 25 | $10.0M | $53.8M | ||
| Q2 25 | $90.9M | $96.7M | ||
| Q1 25 | $16.6M | $44.5M | ||
| Q4 24 | $-10.9M | $39.3M | ||
| Q3 24 | $34.0M | $91.5M | ||
| Q2 24 | $23.2M | $68.1M | ||
| Q1 24 | $6.0M | $70.4M |
自由现金流ASTHCXW
| Q4 25 | $-6.0M | $-45.1M | ||
| Q3 25 | $7.4M | $16.1M | ||
| Q2 25 | $89.5M | $61.9M | ||
| Q1 25 | $13.6M | $20.0M | ||
| Q4 24 | $-13.5M | $16.0M | ||
| Q3 24 | $31.7M | $73.7M | ||
| Q2 24 | $20.4M | $49.3M | ||
| Q1 24 | $5.6M | $59.7M |
自由现金流率ASTHCXW
| Q4 25 | -0.6% | -7.5% | ||
| Q3 25 | 0.8% | 2.8% | ||
| Q2 25 | 13.7% | 11.5% | ||
| Q1 25 | 2.2% | 4.1% | ||
| Q4 24 | -2.0% | 3.3% | ||
| Q3 24 | 6.6% | 15.0% | ||
| Q2 24 | 4.2% | 10.1% | ||
| Q1 24 | 1.4% | 11.9% |
资本支出强度ASTHCXW
| Q4 25 | 0.3% | 7.4% | ||
| Q3 25 | 0.3% | 6.5% | ||
| Q2 25 | 0.2% | 6.5% | ||
| Q1 25 | 0.5% | 5.0% | ||
| Q4 24 | 0.4% | 4.9% | ||
| Q3 24 | 0.5% | 3.6% | ||
| Q2 24 | 0.6% | 3.8% | ||
| Q1 24 | 0.1% | 2.1% |
现金转化率ASTHCXW
| Q4 25 | -0.44× | -0.01× | ||
| Q3 25 | 26.69× | 2.04× | ||
| Q2 25 | 9.65× | 2.51× | ||
| Q1 25 | 2.48× | 1.77× | ||
| Q4 24 | — | 2.04× | ||
| Q3 24 | 2.11× | 4.34× | ||
| Q2 24 | 1.21× | 3.59× | ||
| Q1 24 | 0.40× | 7.37× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
CXW
暂无分部数据
